Agilent | A - Le Bénéfice D'Exploitation

Prix De L'Action
116.09
Variation Quotidienne
0.54 0.47%
Mensuellement
3.64%
Annuel
8.63%
Q2 Prévisions
113.08




Le Bénéfice D'Exploitation Changement Date
Abbott USD 1.85B 399M 2026-03
Agilent USD 353M 90M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 63.9M 13.2M 2025-09
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 538M 26M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Henry Schein USD 186M 12M 2025-12
Illumina USD 256M 6M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 15.3M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Quidel USD -37.3M 667.5M 2025-12
Repligen USD 19.97M 7.29M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Waters USD 270.52M 78.4M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12